Introduction
Our policies and position statements have been developed in partnership with our clinical experts for use by health professionals and clinical teams in NHS North West London ICB. They aim to ensure patients consistently access medicines with safe, clinical, and cost-effective outcomes.
Policies |
|
High Cost Drugs routinely commissioned in North West London 2025 / 2026 |
Medicines not reimbursed through national prices funded by NHS North West London ICB |
This policy, developed in collaboration with system partners involved in NHS prescribing and drug services, outlines best practice recommendations for medicines prescribed in North West London. |
Position Statements |
|
Continuous Glucose Monitoring (CGM) in people with Type 1 Diabetes Mellitus |
This document is temporarily unavailable as it is currently under review. |
|
|
Position statement: Wegovy® for managing overweight and obesity |
This postion statement details the current prescribing arrangements for Wegovy® in NW London. |
Primary Care Rebate Scheme |
|
This document lists the primary care rebate schemes NHS North West London is currently signed up to. |